COWIN portal

Bharat Biotech's intranasal COVID-19 vaccine to cost Rs 800 for private markets

iNCOVACC is the world's first intranasal vaccine for covid to receive approval for the primary two-dose schedule, and as a heterologous booster dose.

published on : 27th December 2022

Bharat Biotech urges Centre to include its intranasal covid vaccine in CoWIN portal

Currently Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V and Biological E Ltd's Corbevax are listed in the CoWin portal.

published on : 11th December 2022